Trial Details
COMPLETEDBasic Information
| Clinical ID | c3547 |
|---|---|
| Identifier | NCT01880424 |
| Trial Title | A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome With Constipation (IBS-C) |
| Interventions | DRUG: Placebo|DRUG: Linaclotide |
Participant Information
| Sponsor | AstraZeneca |
|---|---|
| City | Huntsville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2013-07 |
|---|---|
| Primary Completion Date | 2015-05 |
| Completion Date | 2015-05 |